Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brehmer

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
International Urology and Nephrology|May 6, 1998
Management of haematuria due to secondary renal tumour with selective arterial embolizationJ M Wolff, B Brehmer, G Adam, et al.
Urological Research|October 6, 1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV)D Rohde, B Brehmer, T Kapp, et al.
Der Urologe. Ausg. A|June 27, 2012
[Metastasectomy for renal cell cancer]B Brehmer, C Piper, D Pfister, et al.
Der Urologe. Ausg. A|February 23, 2013
[Documentation of the Governing Body of Prostate Centers (DVPZ)]B Brehmer, R Berges, T Ebert, et al.
Der Urologe. Ausg. A|November 25, 2011
[Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors]P Firek, S Richter, J Jaekel, et al.
British Journal of Urology|April 2, 1998
Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasiaJ M Wolff, T Fandel, H Borchers, et al.
Der Urologe. Ausg. A|May 8, 1999
[Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma]G Jakse, B Brehmer, J M Wolff, et al.
European Urology|August 31, 2001
Perioperative morbidity of the extended radical perineal prostatectomyB Brehmer, H Borchers, R Kirschner-Hermanns, et al.
Der Urologe. Ausg. A|April 3, 2003
[Potency-sparing radical perineal prostatectomy]G Jakse, B Brehmer, H Borchers, et al.
Urologia Internationalis|June 30, 1998
Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasiaJ M Wolff, H Borchers, B Brehmer, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
International Urology and Nephrology|May 6, 1998
Management of haematuria due to secondary renal tumour with selective arterial embolizationJ M Wolff, B Brehmer, G Adam, et al.
Urological Research|October 6, 1998
Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV)D Rohde, B Brehmer, T Kapp, et al.
Der Urologe. Ausg. A|June 27, 2012
[Metastasectomy for renal cell cancer]B Brehmer, C Piper, D Pfister, et al.
Der Urologe. Ausg. A|February 23, 2013
[Documentation of the Governing Body of Prostate Centers (DVPZ)]B Brehmer, R Berges, T Ebert, et al.
Der Urologe. Ausg. A|November 25, 2011
[Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors]P Firek, S Richter, J Jaekel, et al.
British Journal of Urology|April 2, 1998
Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasiaJ M Wolff, T Fandel, H Borchers, et al.
Der Urologe. Ausg. A|May 8, 1999
[Radical perineal prostatectomy without lymphadenectomy. Patients with cT1 + 2, G1 +2, PSA < or = 10 ng/ml prostate carcinoma]G Jakse, B Brehmer, J M Wolff, et al.
European Urology|August 31, 2001
Perioperative morbidity of the extended radical perineal prostatectomyB Brehmer, H Borchers, R Kirschner-Hermanns, et al.
Der Urologe. Ausg. A|April 3, 2003
[Potency-sparing radical perineal prostatectomy]G Jakse, B Brehmer, H Borchers, et al.
Urologia Internationalis|June 30, 1998
Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasiaJ M Wolff, H Borchers, B Brehmer, et al.
Pageof 7